Cox Christopher Nixon 4
4 · Alto Neuroscience, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Cox Christopher Nixon
Director
Transactions
- Award
Stock Option (right to buy)
2026-01-02$11.82/sh+7,189$84,974→ 7,189 totalExercise: $16.59Exp: 2036-01-01→ Common Stock (7,189 underlying)
Footnotes (2)
- [F1]1,797 shares underlying the option shall vest on March 31, 2026, 1,797 shares underlying the option shall vest on June 30, 2026, 1,798 shares underlying the option shall vest on September 30, 2026 and 1,797 shares underlying the option shall vest on December 31, 2026, subject to the Reporting Person's continuous service through each such vesting date.
- [F2]This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $85,000.